1998

Scientific programme


Combined dipyridamole-aspirin treatment: Results of statistical overviews

Chairpersons: Gudrun Boysen (Copenhagen), Hans Göran Hårdemark (Uppsala)

·        A statistical overviewof dipirydamole-aspirin for secondary prevention of stroke – Jan Thiessen (Amsterdam)

·        A statistical overview of dipirydamole-aspirin for prevention of stroke – Peter Sandercock (Edinburgh)

Clopidogrel – two years after the CAPRIE study

Chairpersons: Julien Bogousslavsky (Lausanne), Andreas Terent (Uppsala)

·        Results of the CAPRIE study – J Donald Easton (Rhode Island)

·        A critical review of the CAPRIE study – Peter Sandercock (Edinburgh)

Key issues in secondary stroke prevention

Chairpersons: Rolf Nyberg-Hansen (Oslo), Bo Norrving (Lund)

·        Update on carotid surgery – Charles Warlow (Edinburgh)

·        Antiplatelet therapy and the risk of haemorrhage – Gudrun Boysen (Copenhagen)

·        Anticoagulant therapy and the risk of haemorrhage-experiences from the SPIRIT trial – Ale Algra (Utrecht)

·        Optimal INR values for stroke prevention-value of patient self-check – Andreas Terent (Uppsala)

From trials to clinical routine-when to change medical practice and how to get the message through

Chairpersons: Per Wester (Umeå), Jan-Edwin Olsson (Linköping)

·        We need evidence from large randomised trials and statistical overviews – Charles Warlow (Edinburgh)

·        We need evidence of the effects of treatments in well defined stroke subgroups – Michael Hennirici (Mannheim)

·        Getting the message through-The European Union Stroke Initiative – Markku Kaste (Helsinki)

Thrombolytic therapy in acute stroke

Chairpersons: Johan Rådberg (Linköping), Nils Gunnar Wahlgren (Stockholm)

·        ECASS II: Main results – Werner Hacke (Heidelberg)

·        ECASS II: Acritical analysis - Julien Bogousslavsky (Lausanne)

·        Thrombolytic therapy in the perspective of tPA trials outcomes – Markku Kaste (Helsinki)

Brain plasticity after stroke- a relearning process

Chairpersons: Veronica Murray (Stockholm), Magnus Thorén (Stockholm)

·        Can we enhance relearning after stroke? – Barbro Johansson (Lund)

·        Pharmacological approaches to plasticity- experiences from clinical trials – Louise Martinsson (Stockholm)

Neuroprotective treatment of acute stroke

Chairpersons: Milita Crisby (Stockholm), Christian Blomstrand (Gothenburg)

·        Clomethiazole – Nils Gunnar Wahlgren (Stockholm)

·        Lubeluzole – Hans Christoph Diener (Essen)

·        Piracetam – Jean Marc Orgogozo (Bordeux)

·        Expression of Cytokines in ischaemic stroke, implications for future treatments – Tommy Olsson (Umeå)

Future organisation of stroke services

Chairpersons: Christian Carlström (Stockholm), Hans Göran Hårdemark (Uppsala)

·        Enhanced level of acute management: Prehospital management and intensive care – Hans Göran Hårdemark (Uppsala)

·        Enhanced level of acute management: Experiences from semi-intensive care within a stroke unit – Risto Roine (Helsinki)

·        A logistic model for acute stroke management – Hans Chrisoph Diener (Essen)